<DOC>
	<DOCNO>NCT01085955</DOCNO>
	<brief_summary>Peri-partum cardiomyopathy heart muscle weakness occur follow pregnancy . Research suggest many initial heart injury include virus , pregnancy unknown cause , lead process inflammation heart muscle weaken heart cause cardiomyopathy . Why process occur woman pregnancy well understood differs woman develop cardiomyopathy virus unknown . This study propose look genetic information ( DNA ) well immune system ( body 's response fight infection and/or virus ) find possible cause heart muscle damage occur peripartum cardiomyopathy .</brief_summary>
	<brief_title>Investigation Pregnancy Associate Cardiomyopathy</brief_title>
	<detailed_description>Specific Aim 1 : Evaluate systemic immune activation etiology PPCM . We determine ) degree immune activation PPCM b ) relationship autoimmunity leave ventricular dysfunction time course myocardial recovery , 100 woman enrol 30 center . Subjects blood draw assessment autoantibody , cellular immune activation presentation , 2 month 6 month postpartum , assessment LVEF transthoracic echo presentation , 2 month , 6 month 12 month post partum . This aim explore hypothesis prolonged activation cellular and/or humoral immune system associate great likelihood persistent chronic cardiomyopathy . In addition aim determine genetic clinical predictor LV recovery , evaluate racial difference presentation , remodel recovery . This study evaluate echo parameter dysynchrony , diastolic function , LV size volume determine echo predictor subsequent recovery . In addition racial difference presentation , remodel recovery investigate . Specific Aim 2 : Investigate frequency myocardial injury inflammation cardiac MRI ability tissue characteristic predict subsequent recovery LVEF . Cardiac MRI gadolinium enhancement perform 50 subject PPCM Aim 1 presentation repeat 6 month post partum . We test hypothesis subject extensive injury ( define % myocardium late gadolinium enhancement ) less recovery 6 month . Specific Aim 3 : Establish DNA serum facilitate future investigation pathogenesis peripartum cardiomyopathy . All subject enrol DNA , RNA peripheral blood serum bank entry . Serum repeat 2 6 month post partum .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Patient 16 year age old Diagnosis peripartum cardiomyopathy Presentation enrollment earlier one month preterm later two month post partum . LVEF less OR equal 0.45 echocardiogram Additional inclusion criterion MRI substudy : Must post partum Participant breast feed willing forego breast feed 24 hour post gadolinium . Previous diagnosis cardiomyopathy , valvular disease complex congenital heart disease Evidence CAD ( &gt; 50 % stenosis major epicardial vessel positive noninvasive stress test ) Previous cardiac transplant Chemotherapy chest radiation within 5 year enrollment Evidence ongoing bacterial septicemia ( positive blood culture ) Medical , social , psychiatric condition limit ability comply followup ( Example : alcohol drug abuse ) Additional Exclusion MRI Substudy GFR &lt; 30mL/1.7 m2 MDRD equation ( http : //www.kidney.org/professionals/kdogi/gfr_calculator.cfm ) Currently breast feed unwilling forego 24 hour period post gadolinium Implanted device ( cochlear implant , pacemaker , defibrillator , infusion pump , nerve stimulators , etc ) Cerebral aneurysm clip Swan Ganz catheter intra aortic balloon pump Ocular metal metallic splinter eye Pregnant woman Metal shrapnel bullet Allergy Gadolinium</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>peripartum</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>post pregnancy</keyword>
	<keyword>myocardial recovery</keyword>
	<keyword>pregnant woman peripartum cardiomyopathy</keyword>
</DOC>